# Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects

> **NCT01910571** · PHASE1 · COMPLETED · sponsor: **Piramal Enterprises Limited** · enrollment: 100 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** P7435
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01910571
- **Lead sponsor:** Piramal Enterprises Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01910571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01910571, "Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01910571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*